Abstract
1. Phenelzine (PLZ) is an antidepressant with anxiolytic properties. Acute and chronic PLZ administration increase brain GABA levels, an effect due, at least in part, to an inhibition of the activity of the GABA metabolizing enzyme, GABA transaminase (GABA-T).
2. Previous preliminary reports have indicated that acute PLZ treatment also elevates brain alanine levels. As with GABA, the metabolism of alanine involves a pyridoxal phosphate-dependent transaminase.
3. In the study reported here, the effects of acute PLZ treatment on the levels of various amino acids, some of which are also metabolized by pyridoxal phosphate-dependent transaminases were compared in rat whole brain. Of the 6 amino acids investigated, only GABA and alanine levels were elevated (in a time- and dose-dependent manner).
4. The elevation in brain alanine levels could be explained, at least in part, by a time- and dose-dependent inhibitory effect of PLZ on alanine transaminase (ALA-T), although as with GABA the increases are higher than expected from the degree of enzyme inhibition produced. In addition, we also showed that the elevation in alanine levels and the inhibition of alanine transaminase in the brain are retained after 14 days of PLZ treatment, and that PLZ produces a marked increase in extracellular levels of alanine.
5. These results are discussed in terms of their relevance to synaptic function and to the pharmacological profile of PLZ.
Similar content being viewed by others
REFERENCES
Baker, G. B., Wong, J. T. F., Yeung, J., and Coutts, R. T. (1991). Effects of the antidepressant phenelzine on brain levels of γ-aminobutyric acid. J. Affect. Disord. 21:207-211.
Ballenger, J. C. (1986). Pharmacotherapy of the panic disorders. J. Clin. Psychiatry 47 (Suppl.):27-32.
Chizhmakov, I. V., Kiskin, N. I., Krishtal, O. A., and Tsyndrenko, A. (1989). Glycine action on N-methyl-D-aspartate receptors in rat hippocampal neurons. Neurosci. Lett. 99:131-136.
Dager, S. R., Marro, K. I., Richards, T. L., and Metzger, G. D. (1994). Preliminary application of magnetic resonance spectroscopy to investigate lactate-induced panic. Am. J. Psychiatry 151:57-63.
Dager, S. R., Strauss, W. L., Marro, K. I., Richards, T. L., Metzger, G. D., and Artru, A. A. (1995). Proton magnetic resonance spectroscopy investigation of hyperventilation in subjects with panic disorder and comparison subjects. Am. J. Psychiatry 152:666-672.
Erecinska, M., Nelson, D., Nissim, I., Daikhin, Y., and Yudkoff, M. (1994). Cerebral alanine transport and alanine aminotransferase reaction: Alanine as a source of neuronal glutamate. J. Neurochem. 62:1953-1964.
Griebel, G., Curet, O., Perrault, G., and Sanger, D. J. (1998). Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: Correlation with changes in monoamine-oxidase activity and monoamine levels. Neuropharmacology 37:927-935.
Griffin, J. L., Rae, C., Dixon, R. M., Radda, G. K., and Matthews, P. M. (1998). Excitatory amino acid synthesis in hypoxic brain slices: Does alanine act as a substrate for glutamate production in hypoxia? J. Neurochem. 71:2477-2486.
Hørder, M., and Rej, R. (1983). Alanine transaminase. In Bergmeyer, H. U., Bergmeyer, J., and Grassl, M. (eds.), Methods of Enzymatic Analysis, 3rd edn. Verlag-Chemie, Weinheim, pp. 444-456.
Johnson, M. R., Lydiard, R. B., and Ballenger, J. C. (1995). Panic disorder: Pathophysiology and drug treatment. Drugs 49:328-344.
Laake, J. H., Slyngstad, T. A., Haug, F. M., and Ottersen, O. P. (1995). Glutamine from glial cells is essential for the maintenance of the nerve terminal pool of glutamate: Immunogold evidence from hippocampal slice cultures. J. Neurochem. 65:871-881.
Lai, C. T., Tanay, V. A.-M. I., Charrois, G. J. R., Baker, G. B., and Bateson, A. N. (1998). Effects of phenelzine and imipramine on the steady-state levels of mRNAs that encode glutamic acid decarboxylase (GAD67 and GAD65), the GABA transporter GAT-1 and GABA transaminase in rat cortex. Naunyn-Schmiedeberg's Arch. Pharmacol. 357:32-38.
Liebowitz, M. R., Gorman, J. M., Fyer, A. J., Levitt, M., Dillon, D., Levy, G., Appleby, I. L., Anderson, S., Palij, M., Davies, S. O., Klein, D. F. (1985). Lactate provocation of panic attacks. II. Biochemical and physiological findings. Arch. Gen. Psychiatry 42:709-719.
Löscher, W., and Hörstermann, D. (1994). Differential effects of vigabatrin, γ-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma. Naunyn-Schmiedeberg's Arch. Pharmacol. 349:270-278.
Matthews, C. C., Zielke, H. R., Wollack, J. B., and Fishman, P. S. (2000). Enzymatic degradation protects neurons from glutamate excitotoxicity. J. Neurochem. 75:1045-1052.
McKenna, K. F., McManus, D. J., Baker, G. B., and Coutts, R. T. (1994). Chronic administration of the antidepressant phenelzine and its N-acetyl analogue: effects on GABAergic function. J. Neural Transm. 41(Suppl.):115-122.
McManus, D. J., Baker, G. B., Martin, I. L., Greenshaw, A. J., and McKenna, K. F. (1992). Effects of the antidepressant/antipanic drug phenelzine on GABA concentrations and GABA-transaminase activity in rat brain. Biochem. Pharmacol. 43:2486-2489.
Parent, M. B., Bush, D., Rauw, G., Master, S., Vaccarino, F., and Baker, G. B. (2001). Analysis of amino acids and catecholamines, 5-hydroxytryptamine and their metabolites in brain areas using in vivo microdialysis. Methods 23:11-20.
Parent, M. B., Habib, M. K., and Baker, G. B. (1999). Task-dependent effects of the antidepressant/antipanic drug phenelzine on memory. Psychopharmacology 142:280-288.
Parent, M. B., Habib, M. K., and Baker, G. B. (2000). Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine. Biochem. Pharmacol. 59:1253-1263.
Parent, M. B., Master, S., Kashluba, S., and Baker, G. B. (in press). The antidepressant/antipanic drug phenelzine and its putative metabolite phenylethylidenehydrazine increase extracellular GABA levels in the striatum. Biochem. Pharmacol.
Paslawski, T., Treit, D., Baker, G. B., George, M., and Coutts, R. T. (1996). The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA. Psychopharmacology 127:19-24.
Paslawski, T. M., Sloley, B. D., and Baker, G. B. (1995). Effects of the MAO inhibitor phenelzine on glutamine and GABA concentrations in rat brain. Prog. Brain Res. 106:181-186.
Paulsen, R. E., Odden, E., and Fonnum, F. (1988). Importance of glutamine for gamma-aminobutyric acid synthesis in rat neostriatum in vivo. J. Neurochem. 51:1294-1299.
Paxinos, G., and Watson, C. (1986). The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego, CA.
Perry, T. L., and Hansen, S. (1973). Sustained drug-induced elevation of brain GABA in the rat. J. Neurochem. 21:1167-1175.
Perry, T. L., Kish, S. J., and Hansen, S. (1979). Gamma-Vinyl GABA: Effects of chronic administration on the metabolism of GABA and other amino compounds in rat brain. J. Neurochem. 32:1641-1645.
Phillis, J. W., Ren, J., and O'Regan, M. H. (2000). Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: Studies with DL-threo-beta-benzyloxyaspartate. Brain Res. 868:105-112.
Pitts, F. N., Jr., and McClure, J. N., Jr. (1967). Lactate metabolism in anxiety neurosis. N. Engl. J. Med. 277:1329-1336.
Popov, N., and Matthies, H. (1969). Some effects of monoamine oxidase inhibitors on the metabolism of γ-aminobutyric acid in rat brain. J. Neurochem. 16:899-907.
Preece, N. E., and Cerdan, S. (1996). Metabolic precursors and compartmentation of cerebral GABA in vigabatrin-treated rats. J. Neurochem. 67:1718-1725.
Sterri, S. H., and Fonnum, F. (1978). Isolation of organic anions by extraction with liquid anion exchangers and its application to micromethods for acetylcholinesterase and 4-aminobutyrate aminotransferase. Eur. J. Biochem. 91:215-222.
Tate, S. S., and Meister, A. (1971). Regulation of rat liver glutamine synthetase: Activation by alpha-ketoglutarate and inhibition by glycine, alanine, and carbamyl phosphate. Proc. Natl. Acad. Sci. U.S.A. 68:781-785.
Timmerman, W., and Westerink, B. H. (1997). Brain microdialysis of GABA and glutamate: What does it signify? Synapse 27:242-261.
Waagepetersen, H. S., Sonnewald, U., Larsson, O. M., and Schousboe, A. (2000). A possible role of alanine for ammonia transfer between astrocytes and glutamatergic neurons. J. Neurochem. 75:471-479.
Wong, J. T., Baker, G. B., Coutts, R. T., and Dewhurst, W. G. (1990a). Long-lasting elevation of alanine in brain produced by the antidepressant phenelzine. Brain Res. Bull. 25:179-181.
Wong, J. T. F., Baker, G. B., and Coutts, R. T. (1990b). A rapid, sensitive assay for γ-aminobutyric acid in brain using electron-capture gas chromatography. Res. Commun. Chem. Pathol. Pharmacol. 70:115-124.
Yudkoff, M., Nissim, I., and Hertz, L. (1990). Precursors of glutamic acid nitrogen in primary neuronal cultures: Studies with 15N. Neurochem. Res. 15:1191-1196.
Yudkoff, M., Nissim, I., Hummeler, K., Medow, M., and Pleasure, D. (1986). Utilization of [15N]glutamate by cultured astrocytes. Biochem. J. 234:185-192.
Yudkoff, M., Nissim, I., and Pleasure, D. (1988). Astrocyte metabolism of [15N]glutamine: Implications for the glutamine-glutamate cycle. J. Neurochem. 51:843-850.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tanay, V.AM.I., Parent, M.B., Wong, J.T.F. et al. Effects of the Antidepressant/Antipanic Drug Phenelzine on Alanine and Alanine Transaminase in Rat Brain. Cell Mol Neurobiol 21, 325–339 (2001). https://doi.org/10.1023/A:1012697904299
Issue Date:
DOI: https://doi.org/10.1023/A:1012697904299